To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Amendment to Purchase Order with Boston Scientific Corporation
?Recommendation of the County Administrator ? Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute, on behalf of the Health Services Director, an amendment to purchase order #28564 with Boston Scientific Corporation to increase the payment limit by $184,000 to a new payment limit of $784,000 for the purchase of vascular, urology, endoscopy, and other supplies as needed for Contra Costa Regional Medical Center (CCRMC) with no change to the original term of July 1, 2023 through May 31, 2025.
FISCAL IMPACT:
Approval of this action will result in additional expenditures of up to $184,000 and will be funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets innovative medical devices used in a wide range of specialties, including cardiology, endoscopy, urology, neuromodulation, and peripheral interventions. The company is known for its minimally invasive medical solutions, such as stents, catheters, pacemakers, defibrillators, and surgical tools, which help improve patient outcomes and reduce recovery times. Boston Scientific serves hospitals, healthcare providers, and patients worldwide, focusing on advancing medical technology to enhance patient care and treatment options.
Interventional Urology Products from Boston Scientific are designed for diagnosing and treating urological conditions with minimally invasive solutions. These include stents, laser systems, resectoscopes, and neuromodulation devices for conditions like benign prostatic hyperplasia (BPH), kidney stones, urinary incontinence, and bladder cancer. The products aim to reduce the need for surgery, improve outcomes, and shorten recovery times for patients.
There has been an increase i...
Click here for full text